(Q67903830)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

meta-analysis

0 references

title

Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1136/BMJ.303.6807.884

5 December 2022

language of work or name

English

0 references

publication date

1 October 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

12 October 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1834291

full work available at URL

5 December 2022

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1834291/?tool=EBI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834291

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1834291/pdf/?tool=EBI

5 December 2022

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834291

https://europepmc.org/articles/PMC1671193

5 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834291

https://europepmc.org/articles/PMC1671193?pdf=render

5 December 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834291

https://syndication.highwire.org/content/doi/10.1136/bmj.303.6807.884

5 December 2022

1 reference

https://api.crossref.org/works/10.1136/BMJ.303.6807.884

5 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

303

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

884-893

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

6807

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834291%20AND%20SRC:MED&resulttype=core&format=json

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

19 September 2019

cites work

1 reference

12 December 2020

[Phase III study of carboplatin in ovarian cancer]

1 reference

12 December 2020

Cyclophosphamide-cisplatin versus cyclophosphamide-carboplatin in stage III-IV ovarian carcinoma: a comparison of equally myelosuppressive regimens

1 reference

12 December 2020

Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin

1 reference

12 December 2020

A comparison of the toxicity and efficacy of cisplatin and carboplatin in advanced ovarian cancer. The Swons Gynaecological Cancer Group.

1 reference

12 December 2020

[Prevalence of hepatitis B infection in institutions for the mentally retarded. Epidemiologic characteristics in the province of Vizcaya]

1 reference

12 December 2020

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study

1 reference

12 December 2020

Cisplatin (P) versus cyclophosphamide, adriamycin and cisplatin (CAP) for stage III-IV epithelial ovarian carcinoma: a prospective randomized trial

1 reference

12 December 2020

Estimates of the worldwide frequency of sixteen major cancers in 1980

1 reference

12 December 2020

Melphalan with and without doxorubicin in advanced ovarian cancer.

1 reference

12 December 2020

Randomized trial of the addition of cis-platin (DDP) and/or BCG to cyclophosphamide (CTX) chemotherapy for ovarian carcinoma.

1 reference

12 December 2020

A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma

1 reference

12 December 2020

A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study

1 reference

12 December 2020

Publication bias: the case for an international registry of clinical trials

1 reference

12 December 2020

Single agent vs. combination chemotherapy for ovarian cancer

1 reference

12 December 2020

Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.

1 reference

12 December 2020

A randomized study of single agent vs combination chemotherapy in FIGO stages IIB, III and IV ovarian adenocarcinoma

1 reference

12 December 2020

Intravenous treosulfan versus intravenous treosulfan plus cisplatinum in advanced ovarian carcinoma

1 reference

12 December 2020

Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF)

1 reference

12 December 2020

Long-term survival after chemotherapy for advanced epithelial ovarian carcinoma

1 reference

12 December 2020

Advanced ovarian cancer: a prospective randomised trial of chlorambucil versus combined cyclophosphamide and cis-diamminedichloroplatinum

1 reference

12 December 2020

A controlled clinical trial in advanced ovarian cancer

1 reference

12 December 2020

Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma

1 reference

12 December 2020

[Chemo-(hormonal)-therapy of advanced ovarian neoplasms in FIGO stages III and IV. Prospective SAKK-study 20/71]

1 reference

12 December 2020

Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer. A randomized clinical study

1 reference

12 December 2020

Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycin

1 reference

12 December 2020

Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients

1 reference

12 December 2020

Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report

1 reference

12 December 2020

Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy

1 reference

12 December 2020

Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma

1 reference

12 December 2020

Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary

1 reference

12 December 2020

Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy

1 reference

12 December 2020

Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma

1 reference

12 December 2020

Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer.

1 reference

12 December 2020

A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation

1 reference

12 December 2020

A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma

1 reference

12 December 2020

cis-Platinum, adriamycin, and hexamethylmelamine versus cyclophosphamide in advanced ovarian carcinoma

1 reference

12 December 2020

Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation).

1 reference

12 December 2020

Comparison of melphalan with cyclophosphamide, methotrexate, and 5-fluorouracil in patients with ovarian cancer

1 reference

12 December 2020

Critical review of the quality and development of randomized clinical trials (RCTs) and their influence on the treatment of advanced epithelial ovarian cancer

1 reference

12 December 2020

Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group Study.

1 reference

12 December 2020

Carboplatin in combination therapy for ovarian cancer

1 reference

12 December 2020

An overview in the treatment of advanced ovarian cancer. MRC Gynaecological Cancer Working Party

14

1 reference

https://api.crossref.org/works/10.1136/BMJ.303.6807.884

Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease

5 December 2022

21

1 reference

https://api.crossref.org/works/10.1136/BMJ.303.6807.884

Medical Research Council study on chemotherapy in advanced ovarian cancer. Medical Research Council's Working Party on ovarian cancer

5 December 2022

23

1 reference

https://api.crossref.org/works/10.1136/BMJ.303.6807.884

Chemotherapy of advanced ovarian adenocarcinoma: a randomized comparison of combination versus sequential therapy using chlorambucil and cisplatin

5 December 2022

30

1 reference

https://api.crossref.org/works/10.1136/BMJ.303.6807.884

5 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference